![Space satellite orbiting the earth. Elements of this image furnished by NASA.](https://robbinsllp.com/wp-content/uploads/2021/12/space-satellite-orbiting-the-earth-elements-of-this-image-furnished-by-nasa--300x200.jpg)
Investigation of Redwire Corporation
There Were Material Weaknesses in Redwire Corporation’s (RDW) Internal Controls Over Financial Reporting A class action was filed on behalf of all persons and entities that purchased Redwire Corporation (NYSE:
There Were Material Weaknesses in Redwire Corporation’s (RDW) Internal Controls Over Financial Reporting A class action was filed on behalf of all persons and entities that purchased Redwire Corporation (NYSE:
RenovaCare, Inc. (RCAR) Charged with Securities Fraud According to a class action complaint filed on behalf of RenovaCare, Inc. shareholders, on May 28, 2021, the SEC issued a release
Robbins LLP Investigates KE Holdings Inc. for Corporate Misconduct Robbins LLP is investigating KE Holdings Inc. (NYSE: BEKE) to determine whether certain KE Holdings officers and directors violated the Securities
Lightning eMotors, Inc. (ZEV) May Have Misstated its Operational and Business Prospects A shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired
InnovAge Holdings Corp. (INNV) May Have Misstated its Operational and Business Prospects in its Initial Public Offering Documents A shareholder filed a class action on behalf of all persons and
Spectrum Pharmaceuticals, Inc. (SPPI) Accused of Materially Misrepresenting the Likelihood ROLONTIS Would be Approved by the FDA A class action was filed on behalf of all persons and entities that
Hyzon Motors Inc. (HYZN) Misrepresented its Customer List and Production Capabilities A shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired
Aquestive Therapeutics, Inc. (AQST) May Have Misled Investors About the Likelihood of Approval of its New Drug Application for Libervant Aquestive is a specialty pharmaceutical company that develops products
Exicure, Inc. (XCUR) Failed to Disclose Improprieties Associated with its Preclinical Program for the Treatment of Friedreich’s Ataxia A class action was filed on behalf of all persons and entities
Attorney Advertising. Past results do not guarantee a similar outcome.
5060 Shoreham Pl., Ste. 300 San Diego, CA 92122
Disclaimer | Site Map | Privacy Policy
© 2024 – Robbins LLP
Stock Watch members receive free investment monitoring and notifications.